State of Alaska, Department of Revenue

Position in TGTX — Tg Therapeutics, Inc.

CIK 1370102 JUNEAU, AK

Position in TGTX

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$3,428,365

+$560,051 QoQ

Shares Held

62,402

-27.7% QoQ

Ownership

0.041%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#113

of 423 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

State of Alaska, Department of Revenue holds $93,905,322 across 47 Biotechnology names. TGTX ranks #8 (3.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	31,836	$15,813,895
2	HALO	Halozyme Therapeutics, Inc.	142,422	$11,147,368
3	REGN	Regeneron Pharmaceuticals, Inc.	17,215	$10,734,240
4	JAZZ	Jazz Pharmaceuticals plc	38,357	$9,242,885
5	KRYS	Krystal Biotech, Inc.	13,385	$4,974,801
6	CORT	Corcept Therapeutics Inc	40,107	$3,487,302
7	PTGX	Protagonist Therapeutics, Inc	28,084	$3,442,536
8	TGTX	Tg Therapeutics, Inc. This page	62,402	$3,428,365

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,428,365	62,402	-27.7%	Shares	Sole	2026-07-20
2026-03-31	$2,868,314	86,343	-2.1%	Shares	Sole	2026-04-20
2025-12-31	$2,629,390	88,205	+29.2%	Shares	Sole	2026-01-23
2025-09-30	$2,466,362	68,273	-15.5%	Shares	Sole	2025-10-24
2025-06-30	$2,907,379	80,783	+9.2%	Shares	Sole	2025-07-16
2025-03-31	$2,916,085	73,956	-2.5%	Shares	Sole	2025-04-21
2024-12-31	$2,283,265	75,856	-0.4%	Shares	Sole	2025-01-27
2024-09-30	$1,780,680	76,130	—	Shares	Sole	2024-10-24
No filing history on record for this holder in this stock.